Home / PPGN.SW : SIX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PPGN.SW make money? Does PPGN.SW have pricing power? What's the Earnings Whisper? Will PPGN.SW profit more as the business scales? What is PPGN.SW's management track record? Is PPGN.SW's current price justified?

PolyPeptide Group AG

CHF 44.05 +$20.05 (+83.54%)

SIX · 15 Sep 2026 15:30 UTC

Previous Close

CHF 44

Day Range

CHF 44CHF 44.05

Year Range

CHF 21.8CHF 50.1

Market Cap

1.45B

AVG Volume

113.98K

Trailing/Forward PE

108.49/29.05

PEG ratio

1.47

Dividend Yield

Next Earnings Date

2027-03-09

Primary Exchange

Swiss Exchange

Revenue (EUR)

PPGN.SW Revenue (EUR) by quarter
Period	Revenue (EUR)
26 Q2	236.24M
25 Q4	222.6M
25 Q2	167.1M
24 Q4	201.75M
24 Q2	135.04M
23 Q4	188.54M
23 Q2	131.83M
22 Q4	147.32M
22 Q2	133.66M
21 Q4	146.99M

Net Income (EUR)

PPGN.SW Net Income (EUR) by quarter
Period	Net Income (EUR)
26 Q2	9.07M
25 Q4	5.38M
25 Q2	-26.54M
24 Q4	-8.18M
24 Q2	-11.39M
23 Q4	-17.17M
23 Q2	-34.27M
22 Q4	-2.48M
22 Q2	10.25M
21 Q4	22.64M

Operating Income (EUR)

PPGN.SW Operating Income (EUR) by quarter
Period	Operating Income (EUR)
26 Q2	11.69M
25 Q4	20.33M
25 Q2	-13.72M
24 Q4	5.21M
24 Q2	-12.57M
23 Q4	-13.5M
23 Q2	-22.96M
22 Q4	-2.96M
22 Q2	15.48M
21 Q4	30.88M

EBITDA (EUR)

PPGN.SW EBITDA (EUR) by quarter
Period	EBITDA (EUR)
26 Q2	38.76M
25 Q4	40.27M
25 Q2	4.43M
24 Q4	15.41M
24 Q2	2.87M
23 Q4	-2.42M
23 Q2	-9.89M
22 Q4	6.35M
22 Q2	26.71M
21 Q4	37.85M

Cash Flows (EUR)

PPGN.SW Cash Flows (EUR) by quarter
Period	Cash Flows (EUR)
26 Q2	-18.47M
25 Q4	-31.28M
25 Q2	973K
24 Q4	31.55M
24 Q2	-27.91M
23 Q4	61M
23 Q2	-77.41M
22 Q4	-22.9M
22 Q2	-46.74M
21 Q4	-24.39M

EPS (EUR)

PPGN.SW EPS (EUR) by quarter
Period	EPS (EUR)
26 Q2	0.27
25 Q4	0.16
25 Q2	-0.8
24 Q4	-0.24
24 Q2	-0.35
23 Q4	-0.52
23 Q2	-1.04
22 Q4	-0.08
22 Q2	0.31
21 Q4	0.68

Expenses (EUR)

PPGN.SW Expenses (EUR) by quarter
Period	Expenses (EUR)
26 Q2	85.29M
25 Q4	88.66M
25 Q2	76.7M
24 Q4	79.6M
24 Q2	51.49M
23 Q4	22.2M
23 Q2	50.92M
22 Q4	55.54M
22 Q2	61.43M
21 Q4	59.89M

Cash & Debt (EUR)

PPGN.SW Cash & Debt (EUR) by quarter
Period	Cash & Debt (EUR)
26 Q2	59.21M
25 Q4	74.53M
25 Q2	76.69M
24 Q4	68.28M
24 Q2	48.48M
23 Q4	95.71M
23 Q2	8.98M
22 Q4	37.53M
22 Q2	66.44M
21 Q4	136.3M

Debt ratios

PPGN.SW Debt ratios by quarter
Period	Debt ratios
26 Q2	0.81
25 Q4	0.89
25 Q2	1.17
24 Q4	4.33
24 Q2	-18.14
23 Q4	0.87
23 Q2	1.13
22 Q4	-0.14
22 Q2	-0.31
21 Q4	-0.83

Margins

PPGN.SW Margins by quarter
Period	Margins
26 Q2	22.57%
25 Q4	22.59%
25 Q2	8.25%
24 Q4	13.74%
24 Q2	7.22%
23 Q4	3.95%
23 Q2	-2.03%
22 Q4	10.26%
22 Q2	27.59%
21 Q4	34.97%

Return on Capital

PPGN.SW Return on Capital by quarter
Period	Return on Capital
26 Q2	2.57%
25 Q4	1.58%
25 Q2	-8.02%
24 Q4	-2.29%
24 Q2	-3.16%
23 Q4	-4.5%
23 Q2	-8.92%
22 Q4	-0.59%
22 Q2	2.4%
21 Q4	5.37%

Shares Outstanding

PPGN.SW Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	33.02M
25 Q4	33.01M
25 Q2	33.17M
24 Q4	33.43M
24 Q2	32.53M
23 Q4	32.93M
23 Q2	32.95M
22 Q4	32.92M
22 Q2	33.05M
21 Q4	33.13M

Dividends (EUR)

PPGN.SW Dividends (EUR) by quarter
Period	Dividends (EUR)
Apr 22	0.3

Book Value Per Share (EUR)

PPGN.SW Book Value Per Share (EUR) by quarter
Period	Book Value Per Share (EUR)
26 Q2	10.67
25 Q4	10.31
25 Q2	9.98
24 Q4	10.69
24 Q2	11.06
23 Q4	11.58
23 Q2	11.66
22 Q4	12.81
22 Q2	12.93
21 Q4	12.71

Total Assets (EUR)

PPGN.SW Total Assets (EUR) by quarter
Period	Total Assets (EUR)
26 Q2	863.45M
25 Q4	825.31M
25 Q2	773.07M
24 Q4	756.58M
24 Q2	664.97M
23 Q4	689.09M
23 Q2	589.12M
22 Q4	575.78M
22 Q2	579.25M
21 Q4	595.04M

PE Ratio

PPGN.SW PE Ratio by quarter
Period	PE Ratio
Sep 23	10.93
Sep 23	12.2
Sep 23	13.79
Sep 23	15.23
Aug 23	14.9
Aug 23	15.56
Aug 23	14.54
Aug 23	12.95
Jul 23	13.16
Jul 23	11.73
Jul 23	11.68
Jul 23	10.57
Jun 23	11.5
Jun 23	11.81
Jun 23	13.63
Jun 23	14.65
Jun 23	14.85
May 23	14.78
May 23	14.89
May 23	14.79
May 23	15.75
Apr 23	13.6
Apr 23	12.18
Apr 23	12.16
Apr 23	11.64
Mar 23	11.16
Mar 23	7.54
Mar 23	7.76
Mar 23	9.93
Mar 23	10.5
Feb 23	10.41
Feb 23	10.48
Feb 23	10.32
Feb 23	11.06
Jan 23	11.62
Jan 23	10.78
Jan 23	11.16
Jan 23	11.44
Dec 22	10.44
Dec 22	10.42
Dec 22	9.86
Dec 22	9.67
Dec 22	9.81
Nov 22	14.59
Nov 22	14.46
Nov 22	13.16
Nov 22	11.23
Oct 22	11.54
Oct 22	11.3
Oct 22	12.03
Oct 22	12.36
Sep 22	12.23
Sep 22	13.44
Sep 22	14.12
Sep 22	15.67
Sep 22	15.96
Aug 22	14.44
Aug 22	14.83
Aug 22	18.34
Aug 22	18.61
Jul 22	19.5
Jul 22	20.6
Jul 22	19.5
Jul 22	31.84
Jul 22	28.88
Jun 22	28.92
Jun 22	28.7
Jun 22	30.34
Jun 22	32.48
May 22	30.32
May 22	29.68
May 22	26.76
May 22	30.87
Apr 22	35.31
Apr 22	36.19
Apr 22	34.37
Apr 22	34.31
Apr 22	30.93
Mar 22	31.53
Mar 22	34.26
Mar 22	34.84
Mar 22	35.01
Feb 22	35.98
Feb 22	33.04
Feb 22	35.99
Feb 22	39.17
Jan 22	39.67
Jan 22	39.82
Jan 22	41.49
Jan 22	49.65
Dec 21	59.96
Dec 21	56.64
Dec 21	61.22
Dec 21	55.7
Dec 21	54.5
Nov 21	54.8
Nov 21	48.93
Nov 21	47.59
Nov 21	54.06
Oct 21	50.01

Free Cash Flow Yield

PPGN.SW Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-1.74%
Sep 26	-1.74%
Sep 26	-1.73%
Aug 26	-1.72%
Aug 26	-1.72%
Aug 26	-1.72%
Aug 26	-1.72%
Jul 26	-1.72%
Jul 26	-1.72%
Jul 26	-1.79%
Jul 26	-1.62%
Jul 26	-1.5%
Jun 26	-1.6%
Jun 26	-1.9%
Jun 26	-2.2%
Jun 26	-2.03%
May 26	-1.94%
May 26	-1.92%
May 26	-1.98%
May 26	-1.87%
Apr 26	-1.94%
Apr 26	-2.08%
Apr 26	-2.05%
Apr 26	-2.36%
Apr 26	-2.5%
Mar 26	6.88%
Mar 26	7.33%
Mar 26	7.36%
Mar 26	7.5%
Feb 26	6.99%
Feb 26	6.75%
Feb 26	6.81%
Feb 26	7.04%
Jan 26	6.63%
Jan 26	6.13%
Jan 26	6.5%
Jan 26	6.55%
Dec 25	7.05%
Dec 25	7.28%
Dec 25	7.38%
Dec 25	7.41%
Dec 25	7.48%
Nov 25	7.28%
Nov 25	7.65%
Nov 25	7.68%
Nov 25	7.88%
Oct 25	7.08%
Oct 25	7.04%
Oct 25	7.67%
Oct 25	7.59%
Oct 25	7.38%
Sep 25	-1.5%
Sep 25	-1.39%
Sep 25	-1.45%
Sep 25	-1.37%
Aug 25	-1.32%
Aug 25	-1.27%
Aug 25	-1.32%
Aug 25	-1.65%
Jul 25	-1.56%
Jul 25	-1.44%
Jul 25	-1.61%
Jul 25	-1.7%
Jul 25	-1.7%
Jun 25	-1.75%
Jun 25	-1.81%
Jun 25	-1.75%
Jun 25	-1.67%
May 25	-1.67%
May 25	-1.87%
May 25	-1.81%
May 25	-1.77%
May 25	-1.81%
Apr 25	-2.08%
Apr 25	-2.13%
Apr 25	-2.42%
Apr 25	-2.37%
Mar 25	-11.57%
Mar 25	-11.27%
Mar 25	-10.72%
Mar 25	-10.07%
Feb 25	-9.39%
Feb 25	-8.45%
Feb 25	-8.88%
Feb 25	-8.27%
Jan 25	-7.6%
Jan 25	-7.28%
Jan 25	-7.97%
Jan 25	-7.11%
Jan 25	-6.61%
Dec 24	-6.72%
Dec 24	-6.69%
Dec 24	-7.05%
Dec 24	-6.85%
Nov 24	-6.65%
Nov 24	-6.88%
Nov 24	-6.71%
Nov 24	-6.27%
Nov 24	-6.21%
Oct 24	-6.74%

Price to Sales

PPGN.SW Price to Sales by quarter
Period	Price to Sales
Sep 26	2.11
Sep 26	2.11
Sep 26	2.12
Aug 26	2.13
Aug 26	2.13
Aug 26	2.13
Aug 26	2.14
Jul 26	2.14
Jul 26	2.14
Jul 26	2.06
Jul 26	2.27
Jul 26	2.44
Jun 26	2.29
Jun 26	1.93
Jun 26	1.67
Jun 26	1.8
May 26	1.89
May 26	1.91
May 26	1.86
May 26	1.96
Apr 26	1.89
Apr 26	1.76
Apr 26	1.79
Apr 26	1.56
Apr 26	1.47
Mar 26	1.38
Mar 26	1.29
Mar 26	1.29
Mar 26	1.26
Feb 26	1.36
Feb 26	1.4
Feb 26	1.39
Feb 26	1.35
Jan 26	1.43
Jan 26	1.55
Jan 26	1.46
Jan 26	1.45
Dec 25	1.34
Dec 25	1.3
Dec 25	1.28
Dec 25	1.28
Dec 25	1.27
Nov 25	1.3
Nov 25	1.24
Nov 25	1.23
Nov 25	1.2
Oct 25	1.34
Oct 25	1.35
Oct 25	1.24
Oct 25	1.25
Oct 25	1.28
Sep 25	1.29
Sep 25	1.4
Sep 25	1.34
Sep 25	1.41
Aug 25	1.47
Aug 25	1.53
Aug 25	1.47
Aug 25	1.18
Jul 25	1.24
Jul 25	1.35
Jul 25	1.2
Jul 25	1.15
Jul 25	1.14
Jun 25	1.11
Jun 25	1.07
Jun 25	1.11
Jun 25	1.16
May 25	1.16
May 25	1.04
May 25	1.07
May 25	1.1
May 25	1.07
Apr 25	0.94
Apr 25	0.91
Apr 25	0.8
Apr 25	0.82
Mar 25	0.96
Mar 25	0.99
Mar 25	1.04
Mar 25	1.11
Feb 25	1.19
Feb 25	1.32
Feb 25	1.26
Feb 25	1.35
Jan 25	1.47
Jan 25	1.53
Jan 25	1.4
Jan 25	1.57
Jan 25	1.69
Dec 24	1.66
Dec 24	1.67
Dec 24	1.58
Dec 24	1.63
Nov 24	1.68
Nov 24	1.62
Nov 24	1.66
Nov 24	1.78
Nov 24	1.8
Oct 24	1.66

EV/EBITDA

PPGN.SW EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	25.24
Sep 26	25.27
Sep 26	25.36
Aug 26	25.48
Aug 26	25.51
Aug 26	25.47
Aug 26	25.56
Jul 26	25.56
Jul 26	25.54
Jul 26	24.59
Jul 26	27.03
Jul 26	29.08
Jun 26	27.34
Jun 26	23.19
Jun 26	20.14
Jun 26	21.7
May 26	22.72
May 26	22.94
May 26	22.29
May 26	23.47
Apr 26	22.69
Apr 26	21.24
Apr 26	21.55
Apr 26	18.83
Apr 26	17.82
Mar 26	48.15
Mar 26	45.32
Mar 26	45.09
Mar 26	44.29
Feb 26	47.43
Feb 26	49.07
Feb 26	48.65
Feb 26	47.13
Jan 26	49.92
Jan 26	53.97
Jan 26	50.89
Jan 26	50.56
Dec 25	47.06
Dec 25	45.62
Dec 25	44.98
Dec 25	44.84
Dec 25	44.39
Nov 25	45.58
Nov 25	43.44
Nov 25	43.3
Nov 25	42.21
Oct 25	46.83
Oct 25	47.14
Oct 25	43.36
Oct 25	43.78
Oct 25	44.97
Sep 25	146.61
Sep 25	158.51
Sep 25	151.97
Sep 25	160.09
Aug 25	166.61
Aug 25	172.57
Aug 25	165.79
Aug 25	133.93
Jul 25	141.2
Jul 25	153
Jul 25	136.96
Jul 25	130.46
Jul 25	130.22
Jun 25	126.54
Jun 25	122.45
Jun 25	126.38
Jun 25	132.37
May 25	132.52
May 25	118.54
May 25	122.55
May 25	125.1
May 25	122.58
Apr 25	107.4
Apr 25	104.78
Apr 25	92.6
Apr 25	94.45
Sep 24	54.6
Sep 24	53.45
Sep 24	57.86
Sep 24	55.32
Aug 24	58.17
Aug 24	58.46
Aug 24	54.86
Aug 24	51.97
Aug 24	49.25
Jul 24	49.03
Jul 24	47.54
Jul 24	50.74
Jul 24	51.73
Jun 24	48.03
Jun 24	52.08
Jun 24	55.61
Jun 24	54.08
May 24	55.04
May 24	51.99
May 24	54.25
May 24	53
May 24	49.05
Apr 24	48.86

Price/Operating Cashflow

PPGN.SW Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	9.21
Sep 26	9.22
Sep 26	9.26
Aug 26	9.3
Aug 26	9.31
Aug 26	9.3
Aug 26	9.33
Jul 26	9.33
Jul 26	9.33
Jul 26	8.97
Jul 26	9.89
Jul 26	10.66
Jun 26	10.01
Jun 26	8.44
Jun 26	7.28
Jun 26	7.87
May 26	8.26
May 26	8.34
May 26	8.1
May 26	8.54
Apr 26	8.25
Apr 26	7.7
Apr 26	7.82
Apr 26	6.79
Apr 26	6.41
Mar 26	4.26
Mar 26	4
Mar 26	3.98
Mar 26	3.91
Feb 26	4.19
Feb 26	4.34
Feb 26	4.3
Feb 26	4.16
Jan 26	4.42
Jan 26	4.79
Jan 26	4.51
Jan 26	4.48
Dec 25	4.16
Dec 25	4.03
Dec 25	3.97
Dec 25	3.96
Dec 25	3.92
Nov 25	4.02
Nov 25	3.83
Nov 25	3.82
Nov 25	3.72
Oct 25	4.14
Oct 25	4.17
Oct 25	3.82
Oct 25	3.86
Oct 25	3.97
Sep 25	6.74
Sep 25	7.31
Sep 25	7
Sep 25	7.38
Aug 25	7.69
Aug 25	7.97
Aug 25	7.65
Aug 25	6.14
Jul 25	6.49
Jul 25	7.05
Jul 25	6.29
Jul 25	5.98
Jul 25	5.97
Jun 25	5.79
Jun 25	5.6
Jun 25	5.79
Jun 25	6.07
May 25	6.08
May 25	5.41
May 25	5.6
May 25	5.72
May 25	5.61
Apr 25	4.89
Apr 25	4.76
Apr 25	4.18
Apr 25	4.27
Mar 25	11.6
Mar 25	11.91
Mar 25	12.52
Mar 25	13.34
Feb 25	14.3
Feb 25	15.89
Feb 25	15.12
Feb 25	16.23
Jan 25	17.66
Jan 25	18.44
Jan 25	16.85
Jan 25	18.87
Jan 25	20.31
Dec 24	19.98
Dec 24	20.06
Dec 24	19.04
Dec 24	19.6
Nov 24	20.19
Nov 24	19.5
Nov 24	19.99
Nov 24	21.4
Nov 24	21.61
Oct 24	19.93

Price to Book

PPGN.SW Price to Book by quarter
Period	Price to Book
Sep 26	4.51
Sep 26	4.51
Sep 26	4.53
Aug 26	4.55
Aug 26	4.56
Aug 26	4.55
Aug 26	4.57
Jul 26	4.57
Jul 26	4.56
Jul 26	4.39
Jul 26	4.84
Jul 26	5.22
Jun 26	4.9
Jun 26	4.13
Jun 26	3.56
Jun 26	3.85
May 26	4.04
May 26	4.08
May 26	3.96
May 26	4.18
Apr 26	4.03
Apr 26	3.77
Apr 26	3.82
Apr 26	3.32
Apr 26	3.13
Mar 26	2.88
Mar 26	2.71
Mar 26	2.69
Mar 26	2.64
Feb 26	2.84
Feb 26	2.94
Feb 26	2.91
Feb 26	2.82
Jan 26	2.99
Jan 26	3.24
Jan 26	3.05
Jan 26	3.03
Dec 25	2.81
Dec 25	2.72
Dec 25	2.69
Dec 25	2.68
Dec 25	2.65
Nov 25	2.72
Nov 25	2.59
Nov 25	2.58
Nov 25	2.52
Oct 25	2.8
Oct 25	2.82
Oct 25	2.59
Oct 25	2.61
Oct 25	2.68
Sep 25	2.38
Sep 25	2.58
Sep 25	2.47
Sep 25	2.6
Aug 25	2.71
Aug 25	2.81
Aug 25	2.7
Aug 25	2.16
Jul 25	2.29
Jul 25	2.48
Jul 25	2.22
Jul 25	2.11
Jul 25	2.1
Jun 25	2.04
Jun 25	1.97
Jun 25	2.04
Jun 25	2.14
May 25	2.14
May 25	1.91
May 25	1.97
May 25	2.02
May 25	1.98
Apr 25	1.72
Apr 25	1.68
Apr 25	1.47
Apr 25	1.51
Mar 25	1.61
Mar 25	1.66
Mar 25	1.74
Mar 25	1.86
Feb 25	1.99
Feb 25	2.21
Feb 25	2.1
Feb 25	2.26
Jan 25	2.46
Jan 25	2.57
Jan 25	2.34
Jan 25	2.63
Jan 25	2.83
Dec 24	2.78
Dec 24	2.79
Dec 24	2.65
Dec 24	2.73
Nov 24	2.81
Nov 24	2.71
Nov 24	2.78
Nov 24	2.98
Nov 24	3.01
Oct 24	2.77

No video analysis for this stock yet. Request one from our team.

News: PPGN.SW

gurufocus.com · 31 Aug 2026

Samsung Biologics publishes prospectus for PolyPeptide public tender offer

Samsung Biologics publishes prospectus for PolyPeptide public tender offer PR Newswire INCHEON, South Korea and ZU

gurufocus.com · 19 Jul 2026

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S

prnewswire.com · 19 Jul 2026

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at

AI Analysis

PolyPeptide Group AG

Video analysis: PPGN.SW

News: PPGN.SW

Samsung Biologics publishes prospectus for PolyPeptide public tender offer

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Similar companies